Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade

por Burger, M, Denzinger, S, Hartmann, A, Wieland, W-F, Stoehr, R, Obermann, E C
Publicado 2007

Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics

por Stoehr, R, Hitzenbichler, F, Kneitz, B, Hammerschmied, C G, Burger, M, Tannapfel, A, Hartmann, A
Publicado 2008

MiR-216a: a link between endothelial dysfunction and autophagy

por Menghini, R, Casagrande, V, Marino, A, Marchetti, V, Cardellini, M, Stoehr, R, Rizza, S, Martelli, E, Greco, S, Mauriello, A, Ippoliti, A, Martelli, F, Lauro, R, Federici, M
Publicado 2014

EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice

por Gahr, S, Stoehr, R, Geissinger, E, Ficker, J H, Brueckl, W M, Gschwendtner, A, Gattenloehner, S, Fuchs, F S, Schulz, C, Rieker, R J, Hartmann, A, Ruemmele, P, Dietmaier, W
Publicado 2013

Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients

por Stoehr, C G, Stoehr, R, Wenners, A, Hartmann, A, Bertz, S, Spath, V, Walter, B, Junker, K, Moch, H, Hinze, R, Denzinger, S, Bond, E E, Bond, G L, Bluemke, K, Weigelt, K, Lieb, V, Nolte, E, Fornara, P, Wullich, B, Taubert, H, Wach, S
Publicado 2016